Skip to main content
. 2009 Feb 20;15:386–392.

Table 3. Genotype and allele frequencies of SNPs PD-1.3, PD-1.5, and PD-1.6 in VKH patients and healthy controls.

PDCD1 SNPs VKH patients (%) Healthy controls (%) χ2 p pc Odds ratio (95%CI)
PD-1.3






Genotype






GG
247 (100)
289 (100)




AG






AA






Allele






G
494 (100)
578 (100)




A






PD-1.5






Genotype






CC
131 (53.0)
176 (60.9)
6.786
0.034
0.306

CT
91 (36.8)
99 (34.3)




TT
25 (10.1)
14 (4.8)




Allele






C
353 (71.5)
451 (78.0)
6.132
0.013
0.078
0.705 (0.534–0.930)
T
141 (28.5)
127 (22.0)




PD-1.6






Genotype






AA
124 (50.2)
136 (47.1)
5.171
0.075


AG
108 (43.7)
119 (41.2)




GG
15 (6.1)
34 (11.7)




Allele






A
356 (72.1)
391 (67.6)
2.413
0.12

1.232 (0.947–1.603)
G 138 (27.9) 187 (32.4)

The distribution of genotype frequencies of each SNP in the healthy controls did not show significant deviation from the Hardy-Weinberg equilibrium. The frequency of the C allele and CC genotype of PD-1.5 were lower in VKH patients than in healthy controls, but the differences were not statistically significant following the Bonferroni correction. The genotype and allele frequencies of PD-1.3 and PD-1.6 in VKH patients were not different from those in healthy controls. Only the GG genotype and the G allele of PD-1.3 were identified in all patients and controls